Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has submitted a general update filing to NSE under Regulation 30 of the SEBI Listing Regulations. Regulation 30 filings are used by listed companies to disclose material events or information that may affect investors' decisions. The headline provided does not specify the exact nature of the update, key numbers, or any operational details. Without the full text of the disclosure, the specific content of the update cannot be determined from the information available.
Since the exact subject of the update is not visible in the headline, investors should review the full filing on the NSE/BSE portal to understand any potential implications for the stock or business outlook. No immediate price-impact conclusion can be drawn from this headline alone.